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in the processing of APP, including markedly increasedThe “Down’s” Side of Mitochondria
levels of APP and an amyloidogenic fragment (C99),
reduced levels of secreted APP (APPs), A42 and
the non-amyloidogenic fragment (C83), and intracellular
accumulation of insoluble A42. Interestingly, this al-The mechanisms involved in the development of Alz-
tered pattern of APP processing is reiterated in normalheimer disease-type pathology in patients with Down’s
astrocytes by chemical inhibition of mitochondrial en-syndrome are unclear. However, a paper published in
ergy metabolism. Taking the argument further is thethe February 28 issue of Neuron indicates that mito-
observation that mitochondrial function is significantlychondrial dysfunction is pivotally involved.
impaired in DS astrocytes. DS neurons also exhibit the
same pattern of APP processing as astrocytes, includ-Down’s syndrome (DS) is characterized by the presence
ing increased levels of APP, intracellular accumulationof an extra chromosome 21, producing a distinct pheno-
of A, and reduced secretion of APP and A. The sur-typic profile and mental retardation. A striking feature of
vival of DS cortical neurons in culture is markedly in-the syndrome is that a subset of aged Down’s individuals
creased by recombinant APPs or normal astrocytedevelop Alzheimer disease (AD)-type changes by middle
conditioned medium but not by condition medium de-age. Indeed, since Jervis first described the linkage be-
pleted of APPs. These latter data are consistent withtween DS and AD (Jervis, 1948), many studies have re-
the notion that APPs may be a survival factor for humanvealed that the brain lesions associated with these two
neurons. The reduced secretion of APPs observed indisorders are similar, including senile plaques, neurofi-
cultured DS astrocytes and in tissue samples from DSbrillary tangles, and regionally selective neuronal loss.
brain underscores the potential pathological relevanceThe close linkage between DS and AD may be attrib-
of reduced APPs in DS. The reduced A secretionuted to overexpression of the gene for Amyloid- Pre-
observed in DS astrocytes and brains may not necessar-cursor Protein (APP) on chromosome 21 and the sub-
ily be inconsistent with the early deposition of A42 insequent increased production of Amyloid- (A), the
diffuse plaques in DS patient. As the authors explain, itmajor protein component of senile plaques. Further,
is possible that oxidative modifications of A leads to
since evidence is accumulating that mitochondrial dys-
more highly aggregated and insoluble deposits.
function and oxidative stress play a fundamental role in
Taken together, mitochondrial dysfunction may play
the pathogenesis of AD (Hirai et al., 2001; Nunomura et
a crucial role in the development of AD-type neuropa-
al., 2001), there has been a move toward similar studies
thology in DS patients by promoting aberrant APP pro-
in understanding DS. Mitochondria, the main source of
cessing and intracellular accumulation of A. How is
energy in the cell, are required for normal cellular func-
mitochondrial function impaired? In this regard, the au-
tioning and especially critical for cells highly dependent
thors suggest that impaired mitochondrial function
on aerobic metabolism such as neurons. Mitochondrial
could result from the chronic APP overexpression and
DNA (mtDNA) mutations and free radical reactions may
subsequent increase in A. In addition to direct toxic
damage the organelle and cause decreased ATP pro-
effects of A, the metabolic cost of clearing protein
duction, formation of damaging free radicals, and the aggregation may lead to a state of impaired mitochon-
accumulation of additional mitochondrial damage. In- drial function and ATP depletion, giving rise to a patho-
creasing oxidative and mitochondrial damage, over a logical feedback loop in which protein aggregation in-
period of years, could eventually lead to neuronal cell creases and mitochondrial function is further impaired.
death. In fact, a near perfect correlation between mito- As such, they conclude that therapeutic strategies
chondria abnormalities and oxidative damage was re- should be targeted to the prevention of protein aggrega-
cently described in AD brain (Hirai et al., 2001). Interest- tion and the restoration of normal mitochondrial func-
ingly, several studies have shown that energy depletion tion. In AD, neuronal oxidative damage is actually re-
and oxidative stress can induce amyloidogenic changes duced with increasing senile plaque load (Nunomura et
in APP processing, suggesting a potential link between al., 2001), indicating that increased A production and
mitochondrial dysfunction, oxidative stress, and A pro- subsequent senile plaque formation may be a neuropro-
duction. In DS, there is a reduced level of complex V tective response (Perry et al., 2000). This notion is sup-
(ATP synthase)  chain protein in cortex (Kim et al., ported by the fact that intracellular accumulations of
2000). In addition, mtDNA repair is impaired after oxida- A could be interpreted as compensation for impaired
tive damage in DS fibroblasts (Druzhyna et al., 1998). mitochondrial function in astrocytes and neurons in DS.
Furthermore, DS cortical neurons in culture exhibit intra- In addition, since mitochondria in AD do not exhibit
cellular accumulation of reactive oxygen species (ROS) striking evidence of oxidative damage, as would be ex-
and increased lipid peroxidation leading to neuronal pected if they were the direct producers of free radical
apoptosis (Busciglio and Yankner, 1995). These studies species, it is possible that abnormal mitochondria are
indicate that impaired mitochondrial function and oxida- responsible for supplying a key reactant. One such re-
tive stress are closely associated with DS. actant, H2O2, can react with redox-active iron, which is
In a recent paper in Neuron, Busciglio and colleagues associated with vulnerable neurons in AD, via the Fenton
(2002) report that mitochondrial dysfunction associated reaction, to produce the potent reactive oxygen species,
with DS may result in altered APP metabolism and in- ·OH. Therefore, chelation therapies, as well as therapies
creased neuronal susceptibility. Primary astrocytic cul- that improve mitochondrial function will likely be a promis-
ing target. Finally, further elucidation of the proximal causetures derived from fetal DS brain show profound changes
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wheel, with a central hub that contains the caspase-9Apoptosome:
recruitment domain of Apaf-1 (whose atomic level struc-The Seven-Spoked Death Machine ture has previously been determined). The spokes con-
tain a CED4 nucleotide binding domain (no atomic level
structure available), and contours of the rim allow tenta-
tive assignments of cytochrome c sandwiched between
A paper in the February issue of Molecular Cell de- the two C-terminal subdomains of Apaf-1 (modeled on
scribes the structure of the apoptosome, a multicom- WD40 repeats from other proteins determined at atomic
ponent death machine, deciphered by cryoelectron resolution; Smith et al., 1999). Having tentatively posi-
microscopy. This structure explains the assembly of tioned the components of the machine, Acehan et al.
the machine, the tentative location of the subcompo- then begin to explain how the machine works.
nents, and proposes a mechanism for initiating the In a quiescent state, Apaf-1 is a compact molecule
death signal. with the head (CARD domain) tucked between its feet
(the two propellers formed by the WD40 repeats). Cyto-
chrome c (which is conveniently about the same sizeThe apoptosome is one of the two known molecular
as the CARD) displaces the head, allowing the compactmachines in mammals that arbitrate death in cell fate
structure to stretch out into a more linear molecule thatdecisions (the other is the DISC, the death-inducing
polymerizes upon binding ATP. Interestingly, a polymer-signaling complex that transduces death receptors such
ization model had been proposed earlier for CED4, theas Fas/Apo1; see Figure). The apoptosome receives in-
worm homolog of Apaf-1 (Jaroszewski et al., 2000),tegrated signals from cellular stress and some develop-
based on the ATP-driven opening of an interacting inter-mental cues. Courtesy of cytochrome c released from
face (see Figure).mitochondria, the apoptosome commits a cell to its apo-
The crucial step is to activate caspase-9, but in theptotic execution phase. The past few years have seen
caspase-9-bound form the hub is quite disordered, andthe identification of the components of the apoptosome,
so the exact location and spatial relationship of the cas-and now a recent paper in Molecular Cell has revealed
pase-9 molecules cannot be determined. Thus thethe 3D organization of this machine (Acehan et al., 2002).
mechanism of this crucial step remains obscure. Re-The technique used by Acehan and colleagues relies
markably, in some views Acehan et al. saw hamburger-on electron cryomicroscope images of unstained, fully
shaped images that looked like two apoptosomes sand-
hydrated particles, followed by image reconstruction of
wiching caspase-9. This may be significant, given recent
the molecular machine. evidence which demonstrates that the fundamental
The biochemical function of the apoptosome is to mechanism of caspase-9 activation is via its dimeriza-
activate caspase-9, which then relays the death signal, tion (Renatus et al., 2001). Hence, there is an intriguing
directly activating the executioner caspase-3 and -7 by possibility that the apoptosome works by increasing the
specific and limited proteolysis. The apoptosome’s local concentration of procaspase-9, overcoming the
most basic functional form consists of the apical prote- normal barrier to its dimer-induced activation.
ase caspase-9, its cofactor Apaf-1, and the facilitator Two stacked rings of 7-fold symmetry—where have
protein cytochrome c. With a requirement for dATP (per- we seen that before? Oh, the proteasome (Groll et al.,
haps ATP in vivo), a complex assembles of a size around 1997). But don’t forget bleomycin hydrolase (another
1000 kDa (Cain et al., 1999; Zou et al., 1999). Several 7-fold protease; Zheng et al., 1998), and also the molecu-
observations had previously suggested that the apopto- lar chaperone GroEL (another ATP-dependent machine;
some was an oligomeric assembly, but how it executes Ranson et al., 2001). A possible significance to the num-
the function of activating caspase-9 was hotly debated. ber seven in protein assemblies could be that entropy
To the rescue came the ability to create a recombinant and enthalpy of the structure is balanced under these
apoptosome from its basic components, followed by conditions; the machines are rigid enough to have a
image reconstruction. defined form, but flexible enough to adopt altered con-
formations. But this is just a theory, and perhaps theIn shape the apoptosome resembles a seven-spoked
